Page 46 - Read Online
P. 46

Page 4 of 7               Carilli et al. Mini-invasive Surg 2024;8:9  https://dx.doi.org/10.20517/2574-1225.2023.132

               Table 1. Clinical and demographic baseline patients characteristics
                                                                                 N = 12
                Age (year), median (IQR)                                         58 (50-69)
                Sex, n (%)                                        Male           9 (75.0)
                                                                  Female         3 (25.0)
                BMI, median (IQR)                                                23.4 (21.7-24.6)
                CCI, n (%)                                        0-1            10 (83.3)
                                                                  ≥ 2            2 (16.7)
                Preoperative Hb (g/dL), median (IQR)                             14.4 (13.3-16.3)
                Preoperative eGFR (mL/min), median (IQR)                         86 (74-105)
                Renal tumors per patient, n (%)                   2              9 (75.0)
                                                                  3              2 (16.7)
                                                                  4              1 (8.3)
                Tumor size (mm), median (IQR)                                    34 (27-41)
                R.E.N.A.L. score, median (IQR)                                   6 (5-7)
                Hilar tumor, n (%)                                No             26 (92.8)
                                                                  Yes            2 (7.2)

               IQR: Interquartile range; BMI: body mass index; CCI: Charlson Comorbidity index; Hb: haemoglobin; eGFR: estimated glomerular filtration rate.

               Table 2. Peri- and post-operative outcomes
                                                                                       N = 12
                Console time (min), median (IQR)                                       134 (98-182)
                Estimated blood loss (mL), median (IQR)                                200 (188-312)
                Resection technique, n (%)               Enucleation                   20 (71.4)
                                                         Enucleo-resection             7 (25.0)
                                                         Resection                     1 (3.6)
                Suture technique, n (%)                  Sutureless                    4 (14.3)
                                                         Single-layer                  17 (60.7)
                                                         Double-layer                  7 (25.0)
                Hemostatic agents, n (%)                                               18 (64.3)
                Intraoperative complications, n (%)                                    0 (0)
                Length of hospital stay (days), median (IQR)                           5 (4-6)
                Hb at discharge (g/dL), median (IQR)                                   11.3 (10.5-13.3)
                eGFR at discharge (mL/min), median (IQR)                               79 (60-105)
                eGFR at 30th post-operative day (ml/min), median (IQR)                 80 (62-104)
                Grade ≥ 2 post-operative complications, n (%)                          2 (16.7)
                Post-operative readmissions, n (%)                                     1 (8.3)
                Histology, n (%)                         Benign                        6 (21.4)
                                                         Malignant                     22 (78.6)
                Positive surgical margins, n (%)                                       1 (4.5)

               IQR: Interquartile range; Hb: haemoglobin; eGFR: estimated glomerular filtration rate.


               ipsilateral renal tumours managed by sequential segmental renal artery clamping RAPN showed good renal
               function  preservation  at  five-months  follow-up  (-9.3%  compared  to  baseline),  without  major
                           [15]
               complications . Other recent case series have confirmed the feasibility of off-clamp RAPN for multiple
               ipsilateral renal tumours [16,17] .
   41   42   43   44   45   46   47   48   49   50   51